Video released by ImmuCell highlights importance of newborn calf protection against E. coli and coronavirus.

As part of their ongoing commitment to newborn calf health and shared knowledge, ImmuCell recently added an informational video to the Immediate ImmunityTM YouTube channel. Available at http://www.youtube.com/watch?v=eDH09yl1idk, the video offers advice and experiences from a veterinarian’s viewpoint.

Steve Hayes, DVM and owner of Day 1 Technology, is featured in the piece titled “A Veterinarian’s Perspective: Achieving Immediate Immunity.” Hayes offers advice applicable to both beef and dairy producers on the importance of protecting newborn calves from pathogens.

“In the first two weeks of life, scours is a common problem,” he says, adding that calves must be protected from E. coli, mycoplasma, coronavirus, rotavirus and cryptosporidium.

To promote early calf health and long-term productivity, Hayes encourages producers to complement colostrum feeding programs with a concentrated and targeted antibody product that protects against coronavirus and E. coli. In the video, he explains that producers should utilize products that can be fed without delaying colostrum feeding.

Bobbi (Kunde) Brockmann, director of sales and marketing with ImmuCell, says the video adds to the expertise available on the Immediate Immunity YouTube page.

“The Immediate Immunity YouTube channel continues to be a valuable resource for all cattle producers,” she says. “It’s vital to the beef and dairy industries that producers and veterinarians share their experiences and learn from one another about newborn calf management. The actions we take on day one play a pivotal role in the growth and productivity of the calf’s future.”

ImmuCell Corporation’s (NASDAQ: ICCC) purpose is to create scientifically-proven and practical products that result in a measurable economic impact on animal health and productivity in the dairy and beef industries. Press releases and other information about the Company are available at www.immucell.com. Contact: Michael F. Brigham, President and Chief Executive Officer (207) 878-2770 Ext. 3106